Meeting
2021 ASCO Annual Meeting
Mutant PPM1D and TP53 populate the hematopoietic compartment after peptide receptor radionuclide therapy (PRRT) exposure.
Authors
Abhay Singh
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Abhay Singh , Nuria Mencia-Trinchant , Elizabeth A. Griffiths , Medhavi Gupta , Matthew Gravina , Rutaba Tajammal , Mark G Faber , LunBiao Yan , Eti Sinha , Duane C. Hassane , Monica L. Guzman , Renuka V. Iyer , Eunice S. Wang , Swapna Thota
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Prevention of Primary and Secondary Malignancies
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 10605)
DOI
10.1200/JCO.2021.39.15_suppl.10605
Abstract #
10605
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.
First Author: Edward Christopher Dee
Poster
2023 ASCO Annual Meeting
Large-scale comparative analysis of clinico-genomic characteristics, treatment outcomes and resistant mechanisms of ALK/ROS1/RET-rearranged non-small cell lung cancer (NSCLC) in a nationwide genomic screening project (LC-SCRUM-Asia/TRY).
First Author: Yosuke Kagawa
Poster
2023 ASCO Annual Meeting
Genomic landscape of multiple myeloma with extramedullary disease: Results from a large patient database.
First Author: Mateo Mejia Saldarriaga
Poster
2023 ASCO Annual Meeting
Elucidating the genomic and transcriptomic landscape of L858R vs ex19del EGFR-mutated NSCLC.
First Author: Stephanie Pei Li Saw